Reference is made to the private placement (the “Private Placement“) and the retail offering through PrimaryBid (the “PrimaryBid Offering“) announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-forms related to (i) allocation of shares in the Private Placement; and (ii) share lending to facilitate settlement of tranche 1 of the Private Placement and the PrimaryBid Offering.
Attachment


Đề xuất
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Leanzene Gummies Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
Teenage Mutant Ninja Turtles: Empire City Out Now on Meta Quest, Pico, and Steam VR